EP0585383A4 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
EP0585383A4
EP0585383A4 EP9292913103A EP92913103A EP0585383A4 EP 0585383 A4 EP0585383 A4 EP 0585383A4 EP 9292913103 A EP9292913103 A EP 9292913103A EP 92913103 A EP92913103 A EP 92913103A EP 0585383 A4 EP0585383 A4 EP 0585383A4
Authority
EP
European Patent Office
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP9292913103A
Other languages
English (en)
Other versions
EP0585383A1 (en
Inventor
Gerald Robert Girard
David Taylor Hill
Joseph Weinstock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0585383A1 publication Critical patent/EP0585383A1/en
Publication of EP0585383A4 publication Critical patent/EP0585383A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP9292913103A 1991-05-15 1992-05-14 Chemical compounds Withdrawn EP0585383A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB91105320 1991-05-15
GB919110532A GB9110532D0 (en) 1991-05-15 1991-05-15 Chemical compounds

Publications (2)

Publication Number Publication Date
EP0585383A1 EP0585383A1 (en) 1994-03-09
EP0585383A4 true EP0585383A4 (en) 1994-08-17

Family

ID=10695047

Family Applications (1)

Application Number Title Priority Date Filing Date
EP9292913103A Withdrawn EP0585383A4 (en) 1991-05-15 1992-05-14 Chemical compounds

Country Status (11)

Country Link
EP (1) EP0585383A4 (cg-RX-API-DMAC7.html)
JP (1) JPH06507899A (cg-RX-API-DMAC7.html)
AU (1) AU2156192A (cg-RX-API-DMAC7.html)
GB (1) GB9110532D0 (cg-RX-API-DMAC7.html)
IE (1) IE921539A1 (cg-RX-API-DMAC7.html)
MX (1) MX9202262A (cg-RX-API-DMAC7.html)
NZ (1) NZ242734A (cg-RX-API-DMAC7.html)
PT (1) PT100491A (cg-RX-API-DMAC7.html)
TW (1) TW211010B (cg-RX-API-DMAC7.html)
WO (1) WO1992020651A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA923496B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
KR100587187B1 (ko) * 1997-10-29 2006-10-24 론자 아게 포르밀이미다졸의제조방법
KR100567183B1 (ko) * 1997-11-14 2006-06-13 론자 아게 포르밀이미다졸의제조방법
CA2274994A1 (en) * 1998-06-18 1999-12-18 Lonza Ag Process for the preparation of formylimidazoles
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008315651B2 (en) * 2007-10-22 2012-12-13 Orchid Research Laboratories Limited Histone deacetylase inhibitors
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG52330A1 (en) * 1989-06-14 1998-09-28 Smithkline Beecham Corp Imidazolyl-alkenoic acids
AU640417B2 (en) * 1989-10-25 1993-08-26 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9220651A3 *

Also Published As

Publication number Publication date
WO1992020651A2 (en) 1992-11-26
PT100491A (pt) 1993-09-30
MX9202262A (es) 1992-11-01
AU2156192A (en) 1992-12-30
TW211010B (cg-RX-API-DMAC7.html) 1993-08-11
WO1992020651A3 (en) 1993-02-18
EP0585383A1 (en) 1994-03-09
JPH06507899A (ja) 1994-09-08
NZ242734A (en) 1995-04-27
GB9110532D0 (en) 1991-07-03
IE921539A1 (en) 1992-11-18
ZA923496B (en) 1993-04-28

Similar Documents

Publication Publication Date Title
AP9200385A0 (en) Chemical compounds
GB9103862D0 (en) Chemical compounds
GB9105152D0 (en) Chemical compounds
GB9110625D0 (en) Chemical compounds
GB9110532D0 (en) Chemical compounds
GB9100431D0 (en) Chemical compounds
GB9110635D0 (en) Chemical compounds
GB9109497D0 (en) Chemical compounds
GB9110623D0 (en) Chemical compounds
GB9110507D0 (en) Chemical compounds
GB9100442D0 (en) Chemical compounds
GB9100434D0 (en) Chemical compounds
GB9100441D0 (en) Chemical compounds
GB9108615D0 (en) Chemical compounds
GB9100420D0 (en) Chemical compounds
GB9104889D0 (en) Chemical compounds
GB9110095D0 (en) Chemical compounds
GB9100419D0 (en) Chemical compounds
GB9100433D0 (en) Chemical compounds
GB9100421D0 (en) Chemical compounds
GB9100427D0 (en) Chemical compounds
GB9100628D0 (en) Chemical compounds
GB9100440D0 (en) Chemical compounds
GB9110622D0 (en) Chemical compounds
GB9110620D0 (en) Chemical compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931027

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 19940628

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE FR GB IT LI NL

17Q First examination report despatched

Effective date: 19970428

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990619